Anabasis Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Anabasis General Information

Description

Developer of therapies for eye. The company focuses on research and development of drugs and therapies for ophthalmology and eyes. It also provides laboratories service for drug development and drug trail.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Drug Discovery
Drug Delivery
Acquirer
Dompé
Primary Office
  • San Martino 12
  • 20122 Milan
  • Italy
+39 02 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anabasis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anabasis‘s full profile, request access.

Request a free trial

Anabasis Patents

Anabasis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2129200-A Use of nerve growth factor for therapy of intraocular tissue pathologies Abandoned 29-Jan-1999 0000000000
DE-60027878-D1 Use of the nerve growth factor for the manufacture of a medicament for the treatment of diseases of the interior environment Expired - Lifetime 29-Jan-1999 0000000000
US-20120142591-A1 Method of treating intraoccular tissue pathologies with nerve growth factor Granted 29-Jan-1999 0000000000
US-9468665-B1 Method of treating intraoccular tissue pathologies with nerve growth factor Expired - Fee Related 29-Jan-1999 0000000000 0
ES-2264416-T3 Use of the nervous growth factor for the preparation of a medicinal product for the therapy of intraocular fabric pathologies. Expired - Lifetime 29-Jan-1999 A61K38/185